Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Analysis

Overview Exocrine pancreatic insufficiency occurs when the pancreas does not release enough digestive enzymes.  As a result, food is not digested properly, and the body doesn’t receive the nutrition it needs. In people with chronic pancreatitis, EPI tends to develop 5 to 10 years after the onset of chronic pancreatitis and is present in 30-90% of patients. […]

According to Transparency Market Research’s latest report on the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market for the historical period 2017–2018 and forecast period 2019–2027, rise in prevalence of cystic fibrosis and chronic pancreatitis to escalate the growth of global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market. Moreover, rising cases of diabetes are expected to fuel […]